Personalized Stem Cell Supply for Research
Research tools for biobanking, organ-on-a-chip, 3D bioprinting
N/A (Service)Active
Key Facts
Indication
Research tools for biobanking, organ-on-a-chip, 3D bioprinting
Phase
N/A (Service)
Status
Active
Company
About RevaTis
Revatis is a private, preclinical-stage biotech leveraging a proprietary platform to isolate and expand mesenchymal stem cells (MSCs) from a small muscle biopsy. Its core business model spans both therapeutic applications in veterinary medicine and a service/provider role for human biomedical research, including biobanking, organ-on-a-chip, and 3D bioprinting. Founded in 2015, the company operates with GMP-certified production, has an international footprint, and is built on strong IP from its academic founders. It is currently pre-revenue, focusing on technology development and partnership expansion.
View full company profile